UPC Case Law
Abbott Diabetes Care Inc. v Sinocare Inc. and others
Order of the UPC Court of Appeal of 17 April 2026, UPC CoA 901/2025
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
The Court of Appeal set aside the Hague Local Division's refusal and granted Abbott a preliminary injunction against Sinocare and Menarini for indirect infringement of its glucose-monitoring patent by the GlucoMen iCan system. It also held that features which are non-technical on their own cannot be dropped from the inventive-step assessment where they interact with the rest of the claim, and that a cross-appeal attacking only the reasoning of a decision that favours the cross-appellant is inadmissible.
Key holding
A claim feature may not be excluded from the assessment of inventive step merely because, on its own, it would be a non-invention under Art 52(2) EPC; it may contribute to the technical character of the invention through its interaction with the other features, so the features must be assessed together. Under R 220.1 RoP, which applies to cross-appeals under R 237 RoP, only a party adversely affected may appeal. A cross-appeal whose only purpose is to change part of the reasoning of a first-instance decision that is favourable to the cross-appellant in its result is inadmissible.
Questions decided
- Must event data icons sit on or near the glucose graph line to be 'included' in the timeline graph?
- Can non-technical claim features be disregarded when assessing inventive step?
- Is a supplier of sensor hardware or an app an indirect infringer of a system claim under Art 26 UPCA?
- Did an eight-week delay, measured from product launch, defeat urgency under R 211.4 RoP?
- Is a cross-appeal challenging only the reasoning of a favourable decision admissible?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
More on provisional measures
- Decision · UPC CoA 49/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- Order · UPC CoA 61/2026
SharkNinja Operating LLC v Groupe SEB France and others
The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- Order · UPC CoA 936/2025
Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others
The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- Order · UPC CoA 108/2026
AIM Sport Development AG v TGI Sport Suomi Oy and others
The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- Order · UPC CoA 36/2026
Angelalign Technology Inc. and others v Align Technology, Inc.
The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.
- Order · UPC CoA 19/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal refused Guardant provisional measures against four Sophia Genetics companies for lack of urgency.